甾体和非甾体抗雄激素的受体结合及生物学活性 - Suppr

Suppr

超能文献

Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens.

作者信息

Wakeling A E, Furr B J, Glen A T, Hughes L R

出版信息

J Steroid Biochem. 1981 Dec;15:355-9. doi: 10.1016/0022-4731(81)90297-1.

DOI:10.1016/0022-4731(81)90297-1

PMID:7339263

Abstract

摘要

相似文献

Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens.甾体和非甾体抗雄激素的受体结合及生物学活性

J Steroid Biochem. 1981 Dec;15:355-9. doi: 10.1016/0022-4731(81)90297-1.

The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate.抗雄激素和己烯雌酚对大鼠前列腺胞质受体的影响。

Br J Urol. 1977;49(7):695-700. doi: 10.1111/j.1464-410x.1977.tb04555.x.

Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues.非甾体抗雄激素RU 23908在外周组织和中枢组织中的作用。

J Steroid Biochem. 1979 Jul;11(1A):93-9. doi: 10.1016/0022-4731(79)90281-4.

Estrogen regulation of rat prostate androgen receptor.雌激素对大鼠前列腺雄激素受体的调节作用。

J Steroid Biochem. 1981 Dec;15:403-8. doi: 10.1016/0022-4731(81)90305-8.

Changes in the cytoplasmic androgen receptor of rat ventral prostate after administration of androgens, antiandrogens and anabolic steroids.给予雄激素、抗雄激素和合成代谢类固醇后大鼠腹侧前列腺细胞质雄激素受体的变化。

Endocrinol Jpn. 1980 Aug;27(4):483-93. doi: 10.1507/endocrj1954.27.483.

Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.甾体和非甾体抗雄激素对大鼠腹侧前列腺雄激素受体雄激素结合特性的影响。

Biochim Biophys Acta. 1991 Aug 13;1094(1):103-12. doi: 10.1016/0167-4889(91)90031-r.

The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R 1881 binding to the prostatic androgen receptor and [3H]5 alpha-dihydrotestosterone and [3H]cortisol binding to plasma proteins.酮康唑相关咪唑类药物和抗雄激素对[3H]R1881与前列腺雄激素受体结合以及[3H]5α-二氢睾酮和[3H]皮质醇与血浆蛋白结合的影响。

J Steroid Biochem. 1989 Aug;33(2):251-5. doi: 10.1016/0022-4731(89)90301-4.

The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro.组胺H2受体拮抗剂对体内雄激素作用及体外双氢睾酮与大鼠前列腺雄激素受体结合的影响。

Biochem Pharmacol. 1982 Mar 1;31(5):677-84. doi: 10.1016/0006-2952(82)90449-x.

Androgen and antiandrogen receptor binding.雄激素与抗雄激素受体结合。

Annu Rev Physiol. 1984;46:107-18. doi: 10.1146/annurev.ph.46.030184.000543.

Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.醋酸环丙孕酮可阻止雄激素受体在大鼠前列腺中的易位。

Mol Cell Endocrinol. 1983 Oct;32(2-3):117-29. doi: 10.1016/0303-7207(83)90076-x.

引用本文的文献

Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.恩杂鲁胺与晚期前列腺癌中的雄激素受体阻断：从抗雄激素药物研发历史中汲取的经验教训。

Res Rep Urol. 2018 Feb 16;10:23-32. doi: 10.2147/RRU.S157116. eCollection 2018.

Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors.利用配备抗雄激素的组蛋白去乙酰化酶抑制剂选择性靶向前列腺癌。

ACS Chem Biol. 2013 Nov 15;8(11):2550-60. doi: 10.1021/cb400542w. Epub 2013 Sep 20.

Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.非甾体雄激素受体配体的药代动力学和药效学

Pharm Res. 2006 Aug;23(8):1641-58. doi: 10.1007/s11095-006-9024-3.

In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.具有B环多个取代基的新型雄激素受体配体的体外和体内构效关系

Endocrinology. 2005 Dec;146(12):5444-54. doi: 10.1210/en.2005-0732. Epub 2005 Sep 15.

Chemistry and structural biology of androgen receptor.雄激素受体的化学与结构生物学

Chem Rev. 2005 Sep;105(9):3352-70. doi: 10.1021/cr020456u.

OECD validation of the Hershberger assay in Japan: phase 2 dose response of methyltestosterone, vinclozolin, and p,p'-DDE.经合组织在日本对赫什伯格试验的验证：甲基睾酮、乙烯菌核利和对，对'-滴滴伊的2期剂量反应

Environ Health Perspect. 2003 Dec;111(16):1912-9. doi: 10.1289/ehp.6357.

Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.环丙孕酮。其在前列腺癌中的药理学及治疗效果综述。

Drugs Aging. 1994 Jul;5(1):59-80. doi: 10.2165/00002512-199405010-00006.

3H-cyproterone acetate: binding characteristics to human uterine progestagen receptors.3H-醋酸环丙孕酮：与人子宫孕激素受体的结合特性

J Endocrinol Invest. 1985 Apr;8(2):135-41. doi: 10.1007/BF03350668.

Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity.具有前列腺肿瘤抑制活性的非甾体抗雌激素和部分雌激素。

J Cancer Res Clin Oncol. 1986;112(3):258-65. doi: 10.1007/BF00395920.

Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP.合成雄激素可抑制人前列腺癌细胞系LNCaP中的转化表型。

Br J Cancer. 1991 Jul;64(1):47-53. doi: 10.1038/bjc.1991.237.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验